Log in
Enquire now
‌

US Patent 9457093 Solid dispersions of a ERB2 (HER2) inhibitor

Patent 9457093 was granted and assigned to Array Biopharma Inc. on October, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Array Biopharma Inc.
Array Biopharma Inc.
Current Assignee
Array Biopharma Inc.
Array Biopharma Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9457093
Patent Inventor Names
Jeff Gautschi0
Michael Preigh0
Christopher Donovan Craig0
Christopher M. Lindemann0
Corey Jay Bloom0
Dan Smithey0
David Shank Fry0
Devon Brevard Dubose0
Date of Patent
October 4, 2016
Patent Application Number
14351840
Date Filed
October 12, 2012
Patent Citations Received
0
‌
US Patent 11666572 Treatment of HER2 positive cancers
0
Patent Primary Examiner
‌
Anoop Singh
Patent abstract

A solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion are provided herein. Also, a pharmaceutical composition comprising a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-α]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and uses thereof are provided herein.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9457093 Solid dispersions of a ERB2 (HER2) inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.